SUZANNE OPARIL, MD
Osteopathic Medicine at 19 St, Birmingham, AL
License number
Alabama 04351
Category
Osteopathic Medicine
Type
Cardiovascular Disease
Address
Address
619 19Th St SOUTH, Birmingham, AL 35233
Phone
(205) 934-6600
(205) 731-9701
(205) 731-9701
Personal information
See more information about SUZANNE OPARIL at radaris.comName
Address
Phone
2845 Carlisle Rd, Birmingham, AL 35213
Organization information
See more information about SUZANNE OPARIL at bizstanding.comSuzanne Oparil MD
Birmingham, AL
Industry:
Cardiologist, Internist
Phone:
(205) 934-2580 (Phone)
Addresses:
619 19 St S, Birmingham, AL 35233
703 19 St S, Birmingham, AL 35233
703 19 St S, Birmingham, AL 35233
Suzanne . Oparil
Categories:
Cardiology Physicians & Surgeons
Uab Hospital - Suzanne Oparil MD
1802 6 Ave S, Birmingham, AL 35233
Categories:
Cardiology Physicians & Surgeons, Physicians & Surgeons
Phone:
(205) 996-4000 (Phone)
Professional information
Suzanne Oparil, Birmingham AL
Specialties:
Internal Medicine, Cardiovascular Disease, Cardiology
Work:
University of AL Health Service Foundation-Pediatricss
2000 6Th Ave S, Birmingham, AL 35233
2000 6Th Ave S, Birmingham, AL 35233
Education:
Columbia University (1965)
Dr. Suzanne Oparil, Birmingham AL - MD (Doctor of Medicine)
Specialties:
Internal Medicine
Address:
University Alabama Birmingham
619 19Th St S, Birmingham 35233
(205) 934-2580 (Phone)
619 19Th St S, Birmingham 35233
(205) 934-2580 (Phone)
Certifications:
Internal Medicine, 1970
Awards:
Healthgrades Honor Roll
Languages:
English
Education:
Medical School
Columbia University / College of Physicians And Surgeons
Graduated: 1965
New York Presbyterian Hospital-Columbia Presbyterian Center
Massachusetts General Hospital
Harvard University
Columbia University / College of Physicians And Surgeons
Graduated: 1965
New York Presbyterian Hospital-Columbia Presbyterian Center
Massachusetts General Hospital
Harvard University
Suzanne Oparil, Birmingham AL
Specialties:
Cardiologist
Address:
619 19Th St S, Birmingham, AL 35233
Education:
Columbia University, College of Physicians and Surgeons - Doctor of Medicine
Massachusetts General Hospital - Fellowship - Cardiology
Massachusetts General Hospital - Residency - Family Medicine
Massachusetts General Hospital - Fellowship - Cardiology
Massachusetts General Hospital - Residency - Family Medicine
Board certifications:
American Board of Internal Medicine Certification in Internal Medicine
Method For Determining Diet Program Effectiveness
US Patent:
5639471, Jun 17, 1997
Filed:
Jun 6, 1995
Appl. No.:
8/469516
Inventors:
Allen Chait - Seattle WA
Dan Hatton - Portland OR
R. Brian Haynes - Dundas, CA
Chor San Heng Khoo - Mt. Laurel NJ
Penny Kris-Etherton - State College PA
R. David C. Macnair - King of Prussia PA
David McCarron - Portland OR
Jill Metz - Portland OR
Suzanne Oparil - Birmingham AL
Xavier Pi-Sunyer - New York NY
Larry Resnick - West Bloomfield MI
Judith S. Stern - Lafayette CA
Paula J. Ziegler - Cherry Hill NJ
Dan Hatton - Portland OR
R. Brian Haynes - Dundas, CA
Chor San Heng Khoo - Mt. Laurel NJ
Penny Kris-Etherton - State College PA
R. David C. Macnair - King of Prussia PA
David McCarron - Portland OR
Jill Metz - Portland OR
Suzanne Oparil - Birmingham AL
Xavier Pi-Sunyer - New York NY
Larry Resnick - West Bloomfield MI
Judith S. Stern - Lafayette CA
Paula J. Ziegler - Cherry Hill NJ
Assignee:
Campbell Soup Company - Camden NJ
International Classification:
A61K 4700
US Classification:
424439
Abstract:
The invention is a method for determining the effectiveness of a diet program for administration to a patient having at least one diet-responsive condition. The method includes the steps of selecting a plurality of patients, each having at least one diet-responsive condition; identifying at least one quantifiable indicator of each of the diet-responsive conditions and measuring the at least one indicator for each of the patient during a four week baseline period; and monitoring each of the patients during the baseline period to determine a baseline quality of life. The plurality of patient are divided randomly between a first group and a second group. The diet program is administered to each of the patients in the first group during a ten week intervention period and each of the patient in the second group is maintained on a control diet with known beneficial effects on the at least one diet-responsive condition during the intervention period. The at least one indicator of each of the conditions is monitored for each of the patient after the intervention period.